---
pmid: '19205749'
title: Membranoproliferative glomerulonephritis associated with a mutation in Wilms'
  tumour suppressor gene 1.
authors:
- Bockenhauer D
- van't Hoff W
- Chernin G
- Heeringa SF
- Sebire NJ
journal: Pediatr Nephrol
year: '2009'
full_text_available: false
doi: 10.1007/s00467-009-1135-8
---

# Membranoproliferative glomerulonephritis associated with a mutation in Wilms' tumour suppressor gene 1.
**Authors:** Bockenhauer D, van't Hoff W, Chernin G, Heeringa SF, Sebire NJ
**Journal:** Pediatr Nephrol (2009)
**DOI:** [10.1007/s00467-009-1135-8](https://doi.org/10.1007/s00467-009-1135-8)

## Abstract

1. Pediatr Nephrol. 2009 Jul;24(7):1399-401. doi: 10.1007/s00467-009-1135-8. Epub
 2009 Feb 11.

Membranoproliferative glomerulonephritis associated with a mutation in Wilms' 
tumour suppressor gene 1.

Bockenhauer D(1), van't Hoff W, Chernin G, Heeringa SF, Sebire NJ.

Author information:
(1)Nephrology, Great Ormond Street Hospital for Children NHS Trust, Great Ormond 
Street, London, WC1N 3JH, UK. Detlef.Bockenhauer@nhs.net

Wilms' tumour suppressor gene 1 (WT1) encodes a transcription factor required 
for normal development of the genitourinary system. In the kidney, mutations in 
WT1 can cause diffuse mesangial sclerosis or focal segmental glomerulosclerosis. 
Here, we report on a girl with a mutation in WT1, who developed 
membranoproliferative glomerulonephritis (MPGN) 3 years after completion of 
treatment for Wilms' tumour. This finding extends the spectrum of glomerular 
disease seen with WT1 mutations and could have implications for the screening of 
children with MPGN.

DOI: 10.1007/s00467-009-1135-8
PMID: 19205749 [Indexed for MEDLINE]
